1![FASN inhibition studies in preclinical tumor models identify biomarkers that align with in vitro and in vivo sensitivity to TVB-2640 Timothy S. Heuer, Richard Ventura, Kasia Mordec, Julie Lai, Joanna Waszczuk, Glenn Hamm FASN inhibition studies in preclinical tumor models identify biomarkers that align with in vitro and in vivo sensitivity to TVB-2640 Timothy S. Heuer, Richard Ventura, Kasia Mordec, Julie Lai, Joanna Waszczuk, Glenn Hamm](https://www.pdfsearch.io/img/b2456e52b983d3781cfdd0b8de0bc532.jpg) | Add to Reading ListSource URL: www.3vbio.com- Date: 2015-11-09 14:47:23
|
---|
2![Preclinical studies characterize tumor type sensitivity to FASN inhibition and the mechanism and efficacy of novel drug combinations with TVB-2640 Timothy S. Heuer, Richard Ventura, Julie Lai, Joanna Waszczuk, Kasia Mord Preclinical studies characterize tumor type sensitivity to FASN inhibition and the mechanism and efficacy of novel drug combinations with TVB-2640 Timothy S. Heuer, Richard Ventura, Julie Lai, Joanna Waszczuk, Kasia Mord](https://www.pdfsearch.io/img/c4afa761e9adbef4070f041b3ece0e35.jpg) | Add to Reading ListSource URL: www.3vbio.com- Date: 2016-04-19 06:38:46
|
---|
3![A First-In-Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor TVB-2640 Results of Dose Escalation in Mono and Combination and Evidence of Preliminary Activity A. Brenner1, J. Infante2, M. Patel3, H A First-In-Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor TVB-2640 Results of Dose Escalation in Mono and Combination and Evidence of Preliminary Activity A. Brenner1, J. Infante2, M. Patel3, H](https://www.pdfsearch.io/img/28e3a8b1a751f6f514581b3b51b073f7.jpg) | Add to Reading ListSource URL: www.3vbio.com- Date: 2015-11-06 13:32:52
|
---|
4![FASN inhibitor TVB-2640 shows pharmacodynamic effect and evidence of clinical activity in KRAS mutant NSCLC patients in a Phase 1 study Marie O’Farrell, Tim Heuer, Katharine Grimmer, Richard Crowley, Joanna Waszczuk, M FASN inhibitor TVB-2640 shows pharmacodynamic effect and evidence of clinical activity in KRAS mutant NSCLC patients in a Phase 1 study Marie O’Farrell, Tim Heuer, Katharine Grimmer, Richard Crowley, Joanna Waszczuk, M](https://www.pdfsearch.io/img/aa2d26a6444ef6171dac083c1d0306ea.jpg) | Add to Reading ListSource URL: www.3vbio.comLanguage: English - Date: 2016-04-19 06:39:33
|
---|
5![Preliminary Activity in the First in Human Study of the First-InClass Fatty Acid Synthase (FASN) Inhibitor, TVB-2640 M. Patel1, A. Brenner2, J. Infante3, HT. Arkenau4, E. Borazanci5, G. Falchook6, J. Lopez7, S. Pant8, E. Preliminary Activity in the First in Human Study of the First-InClass Fatty Acid Synthase (FASN) Inhibitor, TVB-2640 M. Patel1, A. Brenner2, J. Infante3, HT. Arkenau4, E. Borazanci5, G. Falchook6, J. Lopez7, S. Pant8, E.](https://www.pdfsearch.io/img/4f04711b9c7eba15cafa40c297bef0af.jpg) | Add to Reading ListSource URL: www.3vbio.comLanguage: English - Date: 2016-03-24 18:34:04
|
---|
6![Fasn 24 Bazille: Der Pleitegeier kreist. Fasn 24 Bazille: Der Pleitegeier kreist.](https://www.pdfsearch.io/img/41a6f40419cb6911026128ad6c2f1495.jpg) | Add to Reading ListSource URL: www.mueues.ch- Date: 2013-02-13 05:52:31
|
---|
7![](https://www.pdfsearch.io/img/b157e41e773b68321a8e96bccaadc233.jpg) | Add to Reading ListSource URL: www.3vbio.comLanguage: English - Date: 2015-09-17 14:38:26
|
---|
8![THE CLINICIAN AND CLINICAL RESEARCH: Barriers and Opportunities PEER REVIEWED | Richard A. Dart, MD, FACP, FCCP, FAHA, FASN, FASH | Robert M. Haws, MD [DOI: CR] THE CLINICIAN AND CLINICAL RESEARCH: Barriers and Opportunities PEER REVIEWED | Richard A. Dart, MD, FACP, FCCP, FAHA, FASN, FASH | Robert M. Haws, MD [DOI: CR]](https://www.pdfsearch.io/img/1333a6a575d692cd99cc4b3a60268fcd.jpg) | Add to Reading ListSource URL: www.acrpnet.orgLanguage: English - Date: 2015-01-20 10:22:24
|
---|
9![• Name: Gerald A. Beathard • Position Title: M.D., Ph.D., FASN • Current Position: University of Texas Medical Branch, Galveston, Texas Clinical Professor, Internal Medicine (1977 – current) Lifeline Vasc • Name: Gerald A. Beathard • Position Title: M.D., Ph.D., FASN • Current Position: University of Texas Medical Branch, Galveston, Texas Clinical Professor, Internal Medicine (1977 – current) Lifeline Vasc](https://www.pdfsearch.io/img/4ad3555a29a5653d76b4b5e1739f26ac.jpg) | Add to Reading ListSource URL: www.das2015-seoul.orgLanguage: English - Date: 2015-02-16 02:11:03
|
---|
10![NUTRITION AND MEDICINE The Troubled Relationship Robert P. Heaney, MD, FACP, FASN Creighton University Osteoporosis Research Center NUTRITION AND MEDICINE The Troubled Relationship Robert P. Heaney, MD, FACP, FASN Creighton University Osteoporosis Research Center](https://www.pdfsearch.io/img/fe71b2e5e3fe15ce2572762a25dbe1e2.jpg) | Add to Reading ListSource URL: grassrootshealth.netLanguage: English - Date: 2014-04-10 06:58:25
|
---|